ROTAVAC(®) does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial.

PubWeight™: 0.76^‹?›

🔗 View Article (PMID 28560356)

Published in Heliyon on May 16, 2017

Authors

Temsunaro Rongsen Chandola¹^,2, Sunita Taneja¹^,2, Nidhi Goyal¹^,2, Kalpana Antony³, Kiran Bhatia¹^,2, Deepak More³^,1, Nita Bhandari¹^,2, Iksung Cho⁴, Krishna Mohan⁵, Sai Prasad⁵, Gvja Harshavardhan⁵, Tataji Surender Rao⁶^,7, Sudhanshu Vrati⁸, Maharaj Kishan Bhan⁹

Author Affiliations

1: Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.
2: Population Science Partnership Centre, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
3: PATH, Mumbai, India.
4: Independent Statistical Consultant, Potomac, MD, USA.
5: Bharat Biotech International Limited, Genome Valley, Andhra Pradesh, India.
6: Clinical Development Services Agency, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, Haryana, India.
7: Department of Biotechnology Ministry of Science and Technology, Government of India.
8: Vaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
9: Indian Institute of Technology, New Delhi, India.

Associated clinical trials:

Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia (ROTAVAC) | NCT03602053

Articles citing this ↘

Rotavirus Vaccines: a story of success with challenges ahead. F1000Res (2017) 0.75

Articles cited by this ↗

Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis (2008) 5.69

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet (2014) 2.35

Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21

Rotavirus vaccines. WHO position paper – January 2013. Wkly Epidemiol Rec (2013) 2.15

Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine (2004) 1.55

Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants. Indian Pediatr (2007) 1.25

A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J Infect Dis (2009) 1.07

Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05

Approximate interval estimation of the difference in binomial parameters: correction for skewness and extension to multiple tables. Biometrics (1990) 1.00

A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine). Hum Vaccin (2007) 0.99

Effect of vitamin A administered at Expanded Program on Immunization contacts on antibody response to oral polio vaccine. Eur J Clin Nutr (2002) 0.97

Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development. Lancet (2014) 0.95

Articles by these authors ⇆

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine (2014) 1.12

Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody. Sci Rep (2015) 0.75